LCN2 and TWEAK synergistically interact with Fn14, leading to epidermal proliferation and inflammation in psoriasis through the MAPK signaling pathway; however, these effects can be reversed by LCN2 knockout. This evidence concerns the gene LCN2 and psoriasis.